Bladder Cancer News

Immunotherapy boost can spare more bladder cancer patients major surgery - The Institute of Cancer Research (ICR)

Immunotherapy boost can spare more bladder cancer patients major surgery The Institute of Cancer Research (ICR)

BCG-Unresponsive Bladder Cancer Care in Community Practice - Gautam Jayram - UroToday

BCG-Unresponsive Bladder Cancer Care in Community Practice - Gautam Jayram UroToday

B7x drives resistance to PD-1/PD-L1 blockade in bladder cancer - EurekAlert!

B7x drives resistance to PD-1/PD-L1 blockade in bladder cancer EurekAlert!

Novel ADCs and Treatment Sequencing Questions: What Made News at ASCO 2026 in Bladder Cancer? - Oncology News Central

Novel ADCs and Treatment Sequencing Questions: What Made News at ASCO 2026 in Bladder Cancer? Oncology News Central

NHS hospitals adopt faster, more accurate at-home bladder cancer test - The Guardian

NHS hospitals adopt faster, more accurate at-home bladder cancer test The Guardian

The Most Asked Bladder Cancer Questions: Signs, Symptoms, Stages and Treatment Options - Cure Today

The Most Asked Bladder Cancer Questions: Signs, Symptoms, Stages and Treatment Options Cure Today

A new sensor could enable earlier detection of bladder cancer - MIT News

A new sensor could enable earlier detection of bladder cancer MIT News

Dr Galsky on the Neoadjuvant Use of ICIs in Bladder Cancer - OncLive

Dr Galsky on the Neoadjuvant Use of ICIs in Bladder Cancer OncLive

FDA Approved Durvalumab Plus BCG for BCG-Naïve High-Risk NMIBC - Oncodaily

FDA Approved Durvalumab Plus BCG for BCG-Naïve High-Risk NMIBC Oncodaily

Imfinzi approved in the US in first and only immunotherapy combination for patients with BCG-naïve, high-risk non-muscle-invasive bladder cancer. - AstraZeneca

Imfinzi approved in the US in first and only immunotherapy combination for patients with BCG-naïve, high-risk non-muscle-invasive bladder cancer. AstraZeneca

Aspirin and Bladder Cancer; Oncology Workforce Shortage; 'Exploding Immune Cells' - MedPage Today

Aspirin and Bladder Cancer; Oncology Workforce Shortage; 'Exploding Immune Cells' MedPage Today

Games - FOX 2

Games FOX 2

An advanced in vitro bladder cancer model integrating bladder cancer spheroids into a healthy human urothelium for preclinical therapeutic testing - Nature

An advanced in vitro bladder cancer model integrating bladder cancer spheroids into a healthy human urothelium for preclinical therapeutic testing Nature

More Than a Diagnosis: Global Survey Exposes the Emotional and Physical Toll of Bladder Cancer Treatment - Gina Carithers - UroToday

More Than a Diagnosis: Global Survey Exposes the Emotional and Physical Toll of Bladder Cancer Treatment - Gina Carithers UroToday

Unpacking the NEXUS-01 Data in Bladder Cancer - OncLive

Unpacking the NEXUS-01 Data in Bladder Cancer OncLive

Doctors hail drug that spares bladder cancer patients ‘life-changing’ surgery - The Guardian

Doctors hail drug that spares bladder cancer patients ‘life-changing’ surgery The Guardian

MoonRISe-3 Trial Design and Enrollment: Erdafitinib Drug-Releasing System in FGFR-Altered Bladder Cancer - Brian Mazzarella - UroToday

MoonRISe-3 Trial Design and Enrollment: Erdafitinib Drug-Releasing System in FGFR-Altered Bladder Cancer - Brian Mazzarella UroToday

Dr Galsky on the Integration of ICIs into the Bladder Cancer Treatment Landscape - OncLive

Dr Galsky on the Integration of ICIs into the Bladder Cancer Treatment Landscape OncLive

Reassurance for bladder cancer patients | Letters - The Guardian

Reassurance for bladder cancer patients | Letters The Guardian

Dr Galsky on the Evolution of the Muscle-Invasive Bladder Cancer Treatment Landscape - OncLive

Dr Galsky on the Evolution of the Muscle-Invasive Bladder Cancer Treatment Landscape OncLive

Photocure & Artera To Partner On Digital Pathology AI Test Evaluation For Bladder Cancer - TradingView

Photocure & Artera To Partner On Digital Pathology AI Test Evaluation For Bladder Cancer TradingView

Advancing Bladder Cancer Care Through Education and Awareness - OncLive

Advancing Bladder Cancer Care Through Education and Awareness OncLive

FDA to Review Expanded Use of Cancer Drug - Los Angeles Business Journal

FDA to Review Expanded Use of Cancer Drug Los Angeles Business Journal

Self-Advocating Helped Change Monique’s Bladder Cancer Treatment Trajectory - AstraZeneca

Self-Advocating Helped Change Monique’s Bladder Cancer Treatment Trajectory AstraZeneca

Bladder Burden Survey Findings on Patient Trust, Unspoken Struggles, and Mental Health in Bladder Cancer - Ashish Kamat - UroToday

Bladder Burden Survey Findings on Patient Trust, Unspoken Struggles, and Mental Health in Bladder Cancer - Ashish Kamat UroToday

Bladder cancer: Treatment advances for urothelial carcinoma - Northside Hospital

Bladder cancer: Treatment advances for urothelial carcinoma Northside Hospital

FDA Approves Durvalumab for Non-Muscle Invasive Bladder Cancer - Oncology News Central

FDA Approves Durvalumab for Non-Muscle Invasive Bladder Cancer Oncology News Central

NYU Langone Urologists Mark 1,000 Cryotherapy Procedures for Minimally Invasive Prostate Cancer Treatment - NYU Langone Health

NYU Langone Urologists Mark 1,000 Cryotherapy Procedures for Minimally Invasive Prostate Cancer Treatment NYU Langone Health

Five stories. One fight. What it means to live with bladder cancer. - Johnson & Johnson

Five stories. One fight. What it means to live with bladder cancer. Johnson & Johnson

GUEST APPEARANCE: Battered, but not defeated, by bladder cancer - Finger Lakes Times

GUEST APPEARANCE: Battered, but not defeated, by bladder cancer Finger Lakes Times

Daraxonrasib Represents a Major Breakthrough for Pancreatic Cancer Care - OncLive

Daraxonrasib Represents a Major Breakthrough for Pancreatic Cancer Care OncLive

Novel ADC Combo Shows Efficacy in Phase 2 Bladder Cancer Data - Oncology News Central

Novel ADC Combo Shows Efficacy in Phase 2 Bladder Cancer Data Oncology News Central

Perioperative Imfinzi plus neoadjuvant EV showed statistically significant and clinically meaningful improvements in event-free survival and overall survival in muscle-invasive bladder cancer in the Phase III VOLGA trial - AstraZeneca

Perioperative Imfinzi plus neoadjuvant EV showed statistically significant and clinically meaningful improvements in event-free survival and overall survival in muscle-invasive bladder cancer in the Phase III VOLGA trial AstraZeneca